Gushengtang Launches Master TCM AI at GovWare 2025, Collaborating with 1doc and August Global Partners

Strategic Insights -

Gushengtang TCM, a leading Chinese medicine group, recently launched its "Master TCM AI" system at GovWare 2025, marking a significant milestone in the integration of traditional Chinese medicine (TCM) with artificial intelligence (AI). This innovative system is the result of a strategic partnership with 1doc, a Singapore-based medical group, and a signed agreement with August Global Partners (AGP) for strategic investment. The Master TCM AI aims to provide clinical support for TCM physicians, leveraging 30 years of clinical experience data from 10 TCM masters.

Key Takeaways:

  • The Master TCM AI is built on 30 years of clinical experience data from 10 TCM masters, including National Master TCM Physician Shi Qi and National Famous TCM Physician Cai Gan.
  • The system covers eight core specialties, including oncology, dermatology, and gastroenterology, and uses experts' diagnostic approaches, case studies, and syndrome differentiation logic as core data.
  • The Master TCM AI supports five key phases, including symptom collection, medical record generation, assisted syndrome differentiation, assisted prescription, and post-consultation follow-up.
  • The system provides clinical assistance to TCM physicians, helping them formulate treatment plans and support clinical capability development.
  • For patients, the Master TCM AI tracks treatment effects and provides health recommendations.
  • Gushengtang operates over 80 clinics and hospitals across China and Singapore, supported by more than 40,000 TCM physicians, and served 5.4 million patient consultations in 2024 alone.

Statistics:

  • 30 years of clinical experience data from 10 TCM masters were used to build the Master TCM AI system.
  • 8 core specialties are covered by the system, including oncology, dermatology, and gastroenterology.
  • 5 key phases are supported by the Master TCM AI, from symptom collection to post-consultation follow-up.
  • Gushengtang operates over 80 clinics and hospitals across China and Singapore.
  • Gushengtang served 5.4 million patient consultations in 2024 alone.
  • The Master TCM AI has the potential to provide clinical assistance to TCM physicians worldwide.

Sources:

  • Gushengtang Holdings Ltd
  • 1doc
  • August Global Partners (AGP)
  • GovWare 2025